Association study of susceptibility loci with specific breast cancer subtypes in Chinese women

被引:28
作者
Zhang, Bo [1 ,2 ]
Li, Yang [3 ,4 ,5 ,6 ]
Li, Longnian [3 ,4 ,5 ,6 ]
Chen, Mengyun [2 ]
Zhang, Cuicui [3 ,4 ]
Zuo, Xian-bo [3 ,4 ,5 ,6 ]
Zhou, Fu-sheng [3 ,4 ,5 ,6 ]
Liang, Bo [3 ,4 ,5 ,6 ]
Zhu, Jun [3 ,4 ,5 ,6 ]
Li, Pan [3 ,4 ,5 ,6 ]
Huang, Zhong-lian [1 ]
Xuan, Han [1 ]
Li, Wei [1 ]
Chen, Zhen-dong [1 ]
机构
[1] Anhui Med Univ, Hosp 2, Dept Oncol, Hefei, Anhui, Peoples R China
[2] Anhui Med Univ, Sch Life Sci, Hefei, Anhui, Peoples R China
[3] Anhui Med Univ, Inst Dermatol, Hosp 1, Hefei, Anhui, Peoples R China
[4] Anhui Med Univ, Dept Dermatol, Hosp 1, Hefei, Anhui, Peoples R China
[5] Anhui Med Univ, Dept Dermatol & Venereol, Hefei, Anhui, Peoples R China
[6] Minist Natl Sci & Technol, State Key Lab Incubat Base Dermatol, Hefei, Anhui, Peoples R China
关键词
Breast cancer; Subtypes; Single nucleotide polymorphisms (SNPs); Association studies; Chinese women; INTERNATIONAL EXPERT CONSENSUS; GENOME-WIDE ASSOCIATION; MOLECULAR PORTRAITS; CELL-PROLIFERATION; PRIMARY THERAPY; EXPRESSION; RISK; TUMORS; GENE; REVEALS;
D O I
10.1007/s10549-014-3041-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To determine whether recent genome-wide association studies that reported 45 susceptibility loci in European women are also risk factors for breast cancer in Chinese women. We selected and genotyped 40 single nucleotide polymorphisms (SNPs) using the Sequenom iPlex platform in a female Chinese cohort of 2,901 breast cancer cases and 2,789 healthy controls. We evaluated these SNPs with the risk of breast cancer and further by estrogen receptor (ER) status, progestin (PR) status, human epidermal growth factor receptor-2 (HER-2) status, and four breast cancer subtypes (Luminal A type, Luminal B type, HER-2 overexpression type and Basal-like type). We first confirmed that the SNP rs9693444 on 8p12 was associated with breast cancer in Chinese women (P = 6.44 x 10(-4)). Furthermore, we identified four susceptibility loci that were associated with specific tumor subtypes. Statistically significant differences were detected with the association of rs6828523 (4q34.1/ADAM29) with ER-positive breast cancer (P = 1.27 x 10(-3)) and the association of rs4849887 (2q14.2) with PR-positive breast cancer (P = 1.29 x 10(-3)). Of the four breast cancer subtypes, the associations of rs12493607 (3p24.1/TGFBR2) with HER-2 overexpression in breast cancer (P = 1.09 x 10(-3)) and rs11075995 (16q12.2/FTO) with basal-like breast cancer (P = 1.64 x 10(-4)) were statistically significant. This study is the first to show that these 5 susceptibility loci (8p12, 4q34.1/ADAM29, 2q14.2, 3p24.1/TGFBR2, and 16q12.2/FTO) correlate with breast cancer (overall and specific subtypes) in Chinese women, which has improved our understanding of the genetic basis of specific breast cancer subtypes.
引用
收藏
页码:503 / 514
页数:12
相关论文
共 31 条
  • [1] [Anonymous], 2013, EUR J HUM GENET, V13, P38
  • [2] Mutational inactivation of TGFBR2 in Microsatellite unstable colon cancer arises from the cooperation of genomic instability and the clonal outgrowth of transforming growth factor β resistant cells
    Biswas, Swati
    Trobridge, Patricia
    Romero-Gallo, Judith
    Billheimer, Dean
    Myeroffs, Lois L.
    Willson, James K. V.
    Markowitz, Sanford D.
    Grady, William M.
    [J]. GENES CHROMOSOMES & CANCER, 2008, 47 (02) : 95 - 106
  • [3] Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
    Cheang, Maggie C. U.
    Chia, Stephen K.
    Voduc, David
    Gao, Dongxia
    Leung, Samuel
    Snider, Jacqueline
    Watson, Mark
    Davies, Sherri
    Bernard, Philip S.
    Parker, Joel S.
    Perou, Charles M.
    Ellis, Matthew J.
    Nielsen, Torsten O.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (10): : 736 - 750
  • [4] Candidate Luminal B Breast Cancer Genes Identified by Genome, Gene Expression and DNA Methylation Profiling
    Cornen, Stephanie
    Guille, Arnaud
    Adelaide, Jose
    Addou-Klouche, Lynda
    Finetti, Pascal
    Saade, Marie-Rose
    Manai, Marwa
    Carbuccia, Nadine
    Bekhouche, Ismahane
    Letessier, Anne
    Raynaud, Stephane
    Charafe-Jauffret, Emmanuelle
    Jacquemier, Jocelyne
    Spicuglia, Salvatore
    de The, Hugues
    Viens, Patrice
    Bertucci, Francois
    Birnbaum, Daniel
    Chaffanet, Max
    [J]. PLOS ONE, 2014, 9 (01):
  • [5] Genome-wide association study identifies novel breast cancer susceptibility loci
    Easton, Douglas F.
    Pooley, Karen A.
    Dunning, Alison M.
    Pharoah, Paul D. P.
    Thompson, Deborah
    Ballinger, Dennis G.
    Struewing, Jeffery P.
    Morrison, Jonathan
    Field, Helen
    Luben, Robert
    Wareham, Nicholas
    Ahmed, Shahana
    Healey, Catherine S.
    Bowman, Richard
    Meyer, Kerstin B.
    Haiman, Christopher A.
    Kolonel, Laurence K.
    Henderson, Brian E.
    Le Marchand, Loic
    Brennan, Paul
    Sangrajrang, Suleeporn
    Gaborieau, Valerie
    Odefrey, Fabrice
    Shen, Chen-Yang
    Wu, Pei-Ei
    Wang, Hui-Chun
    Eccles, Diana
    Evans, D. Gareth
    Peto, Julian
    Fletcher, Olivia
    Johnson, Nichola
    Seal, Sheila
    Stratton, Michael R.
    Rahman, Nazneen
    Chenevix-Trench, Georgia
    Bojesen, Stig E.
    Nordestgaard, Borge G.
    Axelsson, Christen K.
    Garcia-Closas, Montserrat
    Brinton, Louise
    Chanock, Stephen
    Lissowska, Jolanta
    Peplonska, Beata
    Nevanlinna, Heli
    Fagerholm, Rainer
    Eerola, Hannaleena
    Kang, Daehee
    Yoo, Keun-Young
    Noh, Dong-Young
    Ahn, Sei-Hyun
    [J]. NATURE, 2007, 447 (7148) : 1087 - U7
  • [6] Genetic variants associated with breast size also influence breast cancer risk
    Eriksson, Nicholas
    Benton, Geoffrey M.
    Do, Chuong B.
    Kiefer, Amy K.
    Mountain, Joanna L.
    Hinds, David A.
    Francke, Uta
    Tung, Joyce Y.
    [J]. BMC MEDICAL GENETICS, 2012, 13
  • [7] Genome-wide association studies identify four ER negative-specific breast cancer risk loci
    Garcia-Closas, Montserrat
    Couch, Fergus J.
    Lindstrom, Sara
    Michailidouo, Kyriaki
    Schmidt, Marjanka K.
    Brook, Mark N.
    Orr, Nick
    Rhie, Suhn Kyong
    Riboli, Elio
    Feigelson, Heather S.
    Le Marchand, Loic
    Buring, Julie E.
    Eccles, Diana
    Miron, Penelope
    Fasching, Peter A.
    Brauch, Hiltrud
    Chang-Claude, Jenny
    Carpenter, Jane
    Godwin, Andrew K.
    Nevanlinna, Heli
    Giles, Graham G.
    Cox, Angela
    Hopper, John L.
    Bolla, Manjeet K.
    Wang, Qin
    Dennis, Joe
    Dicks, Ed
    Howat, Will J.
    Schoof, Nils
    Bojesen, Stig E.
    Lambrechts, Diether
    Broeks, Annegien
    Andrulis, Irene L.
    Guenel, Pascal
    Burwinkel, Barbara
    Sawyer, Elinor J.
    Hollestelle, Antoinette
    Fletcher, Olivia
    Winqvist, Robert
    Brenner, Hermann
    Mannermaa, Arto
    Hamann, Ute
    Meindl, Alfons
    Lindblom, Annika
    Zheng, Wei
    Devillee, Peter
    Goldberg, Mark S.
    Lubinski, Jan
    Kristensen, Vessela
    Swerdlow, Anthony
    [J]. NATURE GENETICS, 2013, 45 (04) : 392 - 398
  • [8] Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
    Goldhirsch, A.
    Winer, E. P.
    Coates, A. S.
    Gelber, R. D.
    Piccart-Gebhart, M.
    Thuerlimann, B.
    Senn, H. -J.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 (09) : 2206 - 2223
  • [9] Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
    Goldhirsch, A.
    Wood, W. C.
    Coates, A. S.
    Gelber, R. D.
    Thuerlimann, B.
    Senn, H. -J.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (08) : 1736 - 1747
  • [10] Expression of the MAP kinase phosphatase DUSP4 is associated with microsatellite instability in colorectal cancer (CRC) and causes increased cell proliferation
    Groeschl, Benedikt
    Bettstetter, Marcus
    Giedl, Christian
    Woenckhaus, Matthias
    Edmonston, Tina
    Hofstaedter, Ferdinand
    Dietmaier, Wolfgang
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (07) : 1537 - 1546